Safety of Arthritis Drugs, Day 1, Part 4

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke… read more

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Food and Drug Administration. They also responded to questions from members of the committee.

A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close

Report Video Issue

People in this video

More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 1,

More Videos
More information about

Safety of Arthritis Drugs, Day 1, Part 4

218 Views
Program ID:
185572-4
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 23, 2005 | 2:36pm EST | C-SPAN 2

Airing Details

  • Feb 23, 2005 | 2:36pm EST | C-SPAN 2
Purchase a Download

Safety of Arthritis Drugs, Day 1, Part 4

  • MP3 audio - Standard
    Price:
    $0.99